Clinical Trial Update: Phase II Bevacizumab + Tax In Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase II trial evaluating Bevacizumab in combination with Paclitaxel for advanced breast cancer has completed. The study is registered as NCT00027885 and the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)
• Paclitaxel (Taxol) (paclitaxel)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED